Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy (2010)
- Autor:
- Autor USP: SILVA, DENISE DE OLIVEIRA - IQ
- Unidade: IQ
- Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES; COMPOSTOS DE COORDENAÇÃO; ANTINEOPLÁSICOS (ATIVIDADE)
- Language: Inglês
- Imprenta:
- Source:
- Título: Anti-Cancer Agents in Medicinal Chemistry
- ISSN: 1871-5206
- Volume/Número/Paginação/Ano: v. 10, n. 4, p. 312-323, 2010
-
ABNT
SILVA, Denise de Oliveira. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, v. 10, n. 4, p. 312-323, 2010Tradução . . Disponível em: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf. Acesso em: 28 jan. 2026. -
APA
Silva, D. de O. (2010). Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, 10( 4), 312-323. Recuperado de http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
NLM
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2026 jan. 28 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
Vancouver
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2026 jan. 28 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf - Thermodynamics of axial substitution and kinetics of reactions with amino acids for the paddlewheel complex tetrakis(acetato)chloridodiruthenium(II,III)
- A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
- Preparação de microesferas de quitosana reticulada e adsorção de um metalofármaco de cobre-naproxeno
- Estudo da viabilidade do uso de biopolímeros para o encapsulamento de um metalofármaco anti-inflamatório de cobre-ibuprofeno
- TGA/DSC characterization and drug release studies for a biocompatible material containing the drug ibuprofen encapsulated into polymeric cellulose acetate
- Novel (μ-oxo)bis(μ-ibuprofenato)diruthenium(III) complexes derived from the reaction of the paddlewheel structured diruthenium-ibuprofen anticancer metallodrug with imidazole and 2-methyl-imidazole
- Estudos preliminares da interação entre um metalofármaco antiinflamatório de cobre-ibuprofeno e o biopolímero quitosana
- A novel potential antitumor metallodrug of ruthenium-fenbufen: characterization and reactivity with amino acids
- Estudo da influência do PH no comportamento do complexo tetraquis(acetato)cloridodirutênio (II, III)
- Interação dos complexos ('RU'2(OOCCH3)4L2] (L=H2O ou DMF) com adenina
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
